Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| nef Gene Products, Human Immunodeficiency Virus | 11 | 2017 | 51 | 1.510 |
Why?
|
| Exosomes | 6 | 2017 | 101 | 1.000 |
Why?
|
| Peptides | 5 | 2024 | 320 | 0.970 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2024 | 56 | 0.880 |
Why?
|
| Staphylococcal Infections | 1 | 2024 | 58 | 0.870 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 1502 | 0.650 |
Why?
|
| Apoptosis | 7 | 2019 | 1398 | 0.600 |
Why?
|
| Clusterin | 1 | 2017 | 9 | 0.590 |
Why?
|
| HIV-1 | 11 | 2016 | 706 | 0.500 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2015 | 215 | 0.460 |
Why?
|
| HIV Infections | 5 | 2016 | 2303 | 0.390 |
Why?
|
| Gene Products, nef | 4 | 2005 | 19 | 0.390 |
Why?
|
| Receptors, CXCR4 | 3 | 2008 | 69 | 0.370 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 803 | 0.340 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 357 | 0.250 |
Why?
|
| Cell Proliferation | 3 | 2022 | 1198 | 0.250 |
Why?
|
| Cell Line, Tumor | 3 | 2022 | 2231 | 0.240 |
Why?
|
| Molecular Chaperones | 1 | 2024 | 61 | 0.230 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 201 | 0.220 |
Why?
|
| Staphylococcus aureus | 1 | 2024 | 75 | 0.220 |
Why?
|
| Vimentin | 1 | 2022 | 37 | 0.210 |
Why?
|
| Humans | 18 | 2024 | 37093 | 0.210 |
Why?
|
| Peptide Fragments | 2 | 2015 | 308 | 0.210 |
Why?
|
| Biofilms | 1 | 2024 | 168 | 0.200 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 352 | 0.190 |
Why?
|
| Palmitic Acid | 1 | 2019 | 24 | 0.170 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2019 | 28 | 0.170 |
Why?
|
| Virion | 3 | 2016 | 69 | 0.170 |
Why?
|
| Cell Movement | 1 | 2022 | 571 | 0.160 |
Why?
|
| Polyethylene Glycols | 1 | 2017 | 84 | 0.140 |
Why?
|
| Cell Line | 6 | 2019 | 1354 | 0.140 |
Why?
|
| Female | 4 | 2022 | 20969 | 0.130 |
Why?
|
| Transfection | 5 | 2013 | 523 | 0.130 |
Why?
|
| Epithelial Cells | 1 | 2019 | 384 | 0.130 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2013 | 47 | 0.130 |
Why?
|
| China | 1 | 2015 | 196 | 0.130 |
Why?
|
| AIDS Dementia Complex | 1 | 2015 | 102 | 0.120 |
Why?
|
| Blotting, Western | 1 | 2017 | 859 | 0.120 |
Why?
|
| Amino Acid Sequence | 5 | 2012 | 1180 | 0.120 |
Why?
|
| Cytokines | 2 | 2016 | 602 | 0.120 |
Why?
|
| Molecular Sequence Data | 5 | 2012 | 1568 | 0.120 |
Why?
|
| RNA, Viral | 1 | 2015 | 301 | 0.120 |
Why?
|
| Amino Acid Motifs | 3 | 2013 | 91 | 0.110 |
Why?
|
| Sequence Analysis, Protein | 1 | 2012 | 50 | 0.100 |
Why?
|
| Macrophages | 1 | 2015 | 439 | 0.100 |
Why?
|
| Extracellular Space | 1 | 2011 | 35 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2019 | 1908 | 0.100 |
Why?
|
| Prevalence | 1 | 2015 | 1455 | 0.100 |
Why?
|
| Jurkat Cells | 3 | 2008 | 79 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1207 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2015 | 426 | 0.090 |
Why?
|
| Transport Vesicles | 1 | 2010 | 21 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2379 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2016 | 1518 | 0.090 |
Why?
|
| Models, Molecular | 1 | 2012 | 808 | 0.080 |
Why?
|
| Erythrocytes | 1 | 2008 | 111 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 133 | 0.080 |
Why?
|
| Neuroglia | 1 | 2008 | 124 | 0.080 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2008 | 189 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2008 | 81 | 0.070 |
Why?
|
| Aged | 2 | 2015 | 6741 | 0.070 |
Why?
|
| Plasmodium falciparum | 1 | 2008 | 135 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 237 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2008 | 399 | 0.070 |
Why?
|
| United States | 1 | 2015 | 4223 | 0.070 |
Why?
|
| Young Adult | 1 | 2015 | 4268 | 0.060 |
Why?
|
| Male | 3 | 2015 | 20025 | 0.060 |
Why?
|
| Adolescent | 1 | 2015 | 5363 | 0.060 |
Why?
|
| Middle Aged | 2 | 2015 | 10129 | 0.060 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2004 | 8 | 0.060 |
Why?
|
| Cyclosporine | 1 | 2004 | 27 | 0.060 |
Why?
|
| Drug Resistance, Viral | 1 | 2004 | 63 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2004 | 93 | 0.060 |
Why?
|
| Adult | 2 | 2015 | 11712 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 234 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 1609 | 0.050 |
Why?
|
| Mutant Proteins | 2 | 2012 | 51 | 0.050 |
Why?
|
| Animals | 4 | 2019 | 15081 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 448 | 0.050 |
Why?
|
| Brain | 1 | 2008 | 1346 | 0.050 |
Why?
|
| Protein Transport | 2 | 2011 | 302 | 0.040 |
Why?
|
| Mice | 2 | 2008 | 5913 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2005 | 441 | 0.040 |
Why?
|
| Protein Binding | 2 | 2013 | 972 | 0.040 |
Why?
|
| Ultracentrifugation | 1 | 2016 | 16 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2016 | 121 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 306 | 0.030 |
Why?
|
| Viral Load | 1 | 2015 | 312 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 513 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 173 | 0.030 |
Why?
|
| Static Electricity | 1 | 2012 | 78 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 409 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 183 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2012 | 265 | 0.020 |
Why?
|
| Rats | 1 | 2019 | 3483 | 0.020 |
Why?
|
| Amino Acids | 1 | 2012 | 145 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2012 | 216 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2015 | 420 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 408 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 133 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 1492 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 651 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2010 | 26 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1015 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 208 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 295 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 935 | 0.020 |
Why?
|
| Neurons | 1 | 2015 | 1175 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 176 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2008 | 162 | 0.020 |
Why?
|
| Virus Replication | 1 | 2008 | 278 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2008 | 308 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 1095 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2005 | 37 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 90 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2005 | 150 | 0.020 |
Why?
|
| HIV-2 | 1 | 2004 | 9 | 0.010 |
Why?
|
| Cyclophilin A | 1 | 2004 | 15 | 0.010 |
Why?
|
| Hela Cells | 1 | 2004 | 366 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 259 | 0.010 |
Why?
|